Dr Alexis Vaujany
Alexis Vaujany is an associate in the Latham & Watkins’ Paris office and a member of the firm’s Healthcare & Life Sciences Practice.
Alexis primarily advises multinational companies and startups in the pharmaceutical, biotech, medical devices, cosmetics, food and beverage sectors, and assimilated products on a broad variety of complex European, domestic, and cross-border regulatory matters, including products approvals, market access, promotion and advertising, post-market obligations, cannabis-related matters, and general compliance matters.
Alexis has defended a doctoral thesis in pharmaceutical law on the accessibility of biosimilars in the European Union. The research thesis covered the life cycle of biosimilars — from development and comparability to authorization, pricing/reimbursement, and market adoption — assessing IP and regulatory barriers, payers dynamics, and interchangeability/substitution policies.